Buy & Sell Unilever plc (UL) – Unilever plc Price Today
Aura AI Summary
Key Stats
- $124.22BMarket Cap
- Consumer StaplesSector
- -24.81%3M Drawdown
- $150.18BEnterprise Value
- 3.97%Dividend Yield
- 105 daysTypical Hold Time
Unilever plc (UL) is currently valued at a market capitalization of $124.22B, with an enterprise value of $150.18B. Over the past 52 weeks, Unilever plc has traded between a low of $55.45 and a high of $74.59, highlighting its annual price range. Over the past three months, Unilever plc has recorded a drawdown of -24.81%, reflecting recent price volatility. Unilever plc offers a dividend yield of 3.97%, with the most recent dividend of $0.54 paid on 15 May 26. On average, investors hold Unilever plc for approximately 105 days, indicating typical investor behavior on the platform.
About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Most Recent News
Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.
The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...

Hansa Biopharma to present positive 12-month Phase 3 kidney transplant trial results at American Transplant Congress.
Hansa Biopharma announced that its Phase 3 ConfIdeS trial results for kidney transplantation in highly sensitized patients will be presented at the American Transplant Congress on June 22, 2026. The presentation will detail 12-month outcomes, includi...

TruBridge faces class action over financial errors and late report filing, shares drop 10.5%.
TruBridge, Inc. disclosed errors in its previously issued financial statements for 2023 and 2024, leading to a late filing of its 2025 annual report. The errors involve revenue recognition, contract costs, stock-based compensation, and capitalized so...
